Cargando…
Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial
BACKGROUND: The management of severe persistent pulmonary hypertension (PPHN) can be very challenging in many resource-limited centers without access to inhaled nitric oxide or extracorporeal membrane oxygenation. OBJECTIVES: The current study aimed to investigate the efficacy of oral sildenafil and...
Autores principales: | El-Ghandour, Mamdouh, Hammad, Bahaa, Ghanem, Mohamed, Antonios, Manal A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453074/ https://www.ncbi.nlm.nih.gov/pubmed/32856285 http://dx.doi.org/10.1007/s40272-020-00412-4 |
Ejemplares similares
-
Persistent Pulmonary Hypertension of the Newborn: The Efficacy Comparison of Vasodilators Sildenafil Plus Bosentan Versus Sildenafil Plus Beraprost at a Tertiary Childcare Health Facility
por: Adnan, Mudasser, et al.
Publicado: (2021) -
Milrinone: Is Bolus Bad?
por: Kulkarni, Venugopal
Publicado: (2018) -
The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1)
por: EL-Khuffash, Afif, et al.
Publicado: (2022) -
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial
por: Bermejo, Javier, et al.
Publicado: (2018) -
Milrinone role in treatment of septic shock
por: Tomicic, V, et al.
Publicado: (2015)